McKinsey October 8, 2024
Anna Koivuniemi, Matt Fitzpatrick i

Anna Koivuniemi of Google DeepMind explores how AI can revolutionize industries, benefit society, and drive scientific breakthroughs, while emphasizing the critical need for safety and responsible use.

Proteins are vital molecules that perform a wide range of functions essential for life. But since the late 1950s, even with the help of supercomputers, humans have only been able to predict the structure of around 200,000 proteins. Fast forward to today, and in just a few short years, Google DeepMind’s AI model has dramatically increased that number to 200 million structures.

Anna Koivuniemi, who leads Google DeepMind’s Impact Accelerator, recently met with Matt Fitzpatrick, senior partner and global leader of QuantumBlack Labs, the R&D and software development group within QuantumBlack. They discussed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma / Biotech, Technology, Trends
A Trump 2.0 Agenda For Artificial Intelligence
World Children's Day 2024: Preparing Kids For An AI-Driven Future
Leveraging AI to Reach Occupancy Goals in Senior Living Communities: What You Should Know
8 next big healthcare technologies, per Fast Company
Veritone Introduces Data Refinery, Tackling AI’s Data Drought

Share This Article